Central Pacific Bank Trust Division Regeneron Pharmaceuticals, Inc. Transaction History
Central Pacific Bank Trust Division
- $793 Billion
- Q3 2024
A detailed history of Central Pacific Bank Trust Division transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Central Pacific Bank Trust Division holds 737 shares of REGN stock, worth $680,295. This represents 0.1% of its overall portfolio holdings.
Number of Shares
737
Previous 742
0.67%
Holding current value
$680,295
Previous $780 Million
0.65%
% of portfolio
0.1%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,481Shares Held
85.5MCall Options Held
908KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$8.3 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$7.8 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$7.64 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.47 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$4.28 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $98.9B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...